Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2022-09-09 00:00:00 ET · period of report 2022-09-08 · accession 0001209191-22-049255 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-09-09 | 2022-09-08 | KPTI | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $5.23 | -3,479 | 623.0K | -0.6% | -$18.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-08 | S | D | 16 | $5.26 | 626,461 | D | — | — | |
| 2 | Common | Common Stock | 2022-09-08 | S | D | 3,463 | $5.23 | 622,998 | D | — | — |